These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 16524673
1. Molecular regulation of receptor tyrosine kinases in hematopoietic malignancies. Correll PH, Paulson RF, Wei X. Gene; 2006 Jun 07; 374():26-38. PubMed ID: 16524673 [Abstract] [Full Text] [Related]
2. Molecular genetics of human leukemias: new insights into therapy. Gilliland DG. Semin Hematol; 2002 Oct 07; 39(4 Suppl 3):6-11. PubMed ID: 12447846 [Abstract] [Full Text] [Related]
3. The envelope glycoprotein of friend spleen focus-forming virus covalently interacts with and constitutively activates a truncated form of the receptor tyrosine kinase Stk. Nishigaki K, Thompson D, Hanson C, Yugawa T, Ruscetti S. J Virol; 2001 Sep 07; 75(17):7893-903. PubMed ID: 11483734 [Abstract] [Full Text] [Related]
5. Oncogenic receptor tyrosine kinase in leukemia. Mizuki M, Ueda S, Matsumura I, Ishiko J, Schwäble J, Serve H, Kanakura Y. Cell Mol Biol (Noisy-le-grand); 2003 Sep 07; 49(6):907-22. PubMed ID: 14656048 [Abstract] [Full Text] [Related]
6. A novel Stat3 binding motif in Gab2 mediates transformation of primary hematopoietic cells by the Stk/Ron receptor tyrosine kinase in response to Friend virus infection. Ni S, Zhao C, Feng GS, Paulson RF, Correll PH. Mol Cell Biol; 2007 May 07; 27(10):3708-15. PubMed ID: 17353274 [Abstract] [Full Text] [Related]
7. Resistance to friend virus-induced erythroleukemia in W/W(v) mice is caused by a spleen-specific defect which results in a severe reduction in target cells and a lack of Sf-Stk expression. Subramanian A, Teal HE, Correll PH, Paulson RF. J Virol; 2005 Dec 07; 79(23):14586-94. PubMed ID: 16282458 [Abstract] [Full Text] [Related]
8. Sf-Stk kinase activity and the Grb2 binding site are required for Epo-independent growth of primary erythroblasts infected with Friend virus. Finkelstein LD, Ney PA, Liu QP, Paulson RF, Correll PH. Oncogene; 2002 May 16; 21(22):3562-70. PubMed ID: 12032858 [Abstract] [Full Text] [Related]
9. Genetics of myeloid leukemias. Kelly LM, Gilliland DG. Annu Rev Genomics Hum Genet; 2002 May 16; 3():179-98. PubMed ID: 12194988 [Abstract] [Full Text] [Related]
11. Receptor association and tyrosine phosphorylation of S6 kinases. Rebholz H, Panasyuk G, Fenton T, Nemazanyy I, Valovka T, Flajolet M, Ronnstrand L, Stephens L, West A, Gout IT. FEBS J; 2006 May 16; 273(9):2023-36. PubMed ID: 16640565 [Abstract] [Full Text] [Related]
15. Fv2 encodes a truncated form of the Stk receptor tyrosine kinase. Persons DA, Paulson RF, Loyd MR, Herley MT, Bodner SM, Bernstein A, Correll PH, Ney PA. Nat Genet; 1999 Oct 16; 23(2):159-65. PubMed ID: 10508511 [Abstract] [Full Text] [Related]
16. Receptor tyrosine kinases and their activation in melanoma. Easty DJ, Gray SG, O'Byrne KJ, O'Donnell D, Bennett DC. Pigment Cell Melanoma Res; 2011 Jun 16; 24(3):446-61. PubMed ID: 21320293 [Abstract] [Full Text] [Related]
17. The sema domain. Gherardi E, Love CA, Esnouf RM, Jones EY. Curr Opin Struct Biol; 2004 Dec 16; 14(6):669-78. PubMed ID: 15582390 [Abstract] [Full Text] [Related]
18. Receptor tyrosine kinases: from biology to pathology. Choura M, Rebaï A. J Recept Signal Transduct Res; 2011 Dec 16; 31(6):387-94. PubMed ID: 22040163 [Abstract] [Full Text] [Related]